Company Overview
WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer and distributor of cannabis products for both the medical and adult-use markets. The Company owns and operates two facilities: a 26,000 sq. ft. indoor facility in Aylmer, Ontario and a state-of-the-art greenhouse and outdoor facility located in Strathroy, Ontario. The Company currently has 136,000 square feet of licensed production space and is expected to have a total footprint of more than 550,000 square feet of indoor and greenhouse production in addition to more than 25 acres of outdoor cultivation space online in the first half of 2019. WeedMD has a multi-channeled distribution strategy that includes selling directly to medical patients, strategic relationships across the seniors’ market and supply agreements with Shoppers Drug Mart as well as six provincial distribution agencies.
[stock_market_chart symbol=”WMD.V” range=”1y” settings='{“primaryChartType”:”smoothedLine”,”width”:”100%”,”height”:”350px”,”marginTop”:0,”marginBottom”:0,”marginLeft”:10,”marginRight”:10,”primaryPanelTitle”:”Price”,”secondaryPanelTitle”:”Volume”,”fontSize”:13,”color”:”#383838″,”primaryLineColor”:”#000″,”primaryLineColorAlpha”:0.15,”secondaryLineColor”:”#000″,”secondaryLineColorAlpha”:0.15,”backgroundColor”:”#fff”,”gridColor”:”#e0e0e0″,”gridAlpha”:0.8,”cursorColor”:”#ba0000″,”cursorAlpha”:0.8,”scrollbarBackgroundColor”:”#fff”,”scrollbarSelectedBackgroundColor”:”#000″,”scrollbarGraphFillColor”:”#000″,”scrollbarSelectedGraphFillColor”:”#000″,”primaryLineThickness”:0,”secondaryLineThickness”:0,”gridThickness”:0,”precision”:2,”thousandsSeparator”:”,”,”decimalSeparator”:”.”,”usePrefixes”:false,”mouseWheelZoomEnabled”:false,”cursorEnabled”:false,”exportEnabled”:false,”scrollbarEnabled”:false,”legendEnabled”:false,”periods”:”1W,1M,6M,YTD,1Y,ALL”,”defaultPeriod”:”1y”}’]
Investor Presentation
Key Share Information
| Current Share Price | $0.28 |
| Market Capitalization (in Millions) | $31.88 |
| Last Quarter Reported Ending | 3/31/2019 |
| Shares Outstanding (in Millions) | 113.86 |
| Options (in Millions) | 10.21 |
| Warrants (in Millions) | 11.88 |
| Fully Diluted Shares (in Millions) | 135.95 |
| Enterprise Value | $16.17 |
| TTM Revenue | $15.99 |
| TTM Growth Margin % | 79.76% |
| TTM Operating Expenses | $28.02 |
| TTM OCF | -$5.59 |
| P/S TTM | 2.07 |
| P/S (Last Quarter Run Rate) | 2.24 |
Key Balance Sheet Information (in Millions $CAD)
| CYQ1'18 | CYQ2'18 | CYQ3'18 | CYQ4'18 | CYQ1'19 | |
|---|---|---|---|---|---|
| Cash | $48.46 | $39.50 | $36.06 | $21.22 | $16.85 |
| Biological Assets | $0.70 | $0.92 | $1.99 | $2.15 | $5.14 |
| Inventory | $2.77 | $3.51 | $5.40 | $5.83 | $8.71 |
| Total Assets | $73.80 | $73.77 | $87.70 | $88.07 | $130.75 |
| Net Tangible Assets | $73.80 | $73.77 | $87.70 | $88.07 | $130.75 |
| Intangibles/Goodwill | |||||
| Total Liabilities | $12.52 | $6.95 | $9.86 | $10.98 | $48.95 |
Key Operating Items (Quarterly in Millions $CAD)
| CYQ1'18 | CYQ2'18 | CYQ3'18 | CYQ4'18 | CYQ1'19 | |
|---|---|---|---|---|---|
| Revenue | $1.14 | $2.09 | $2.00 | $8.20 | $3.69 |
| Change in Fair Value of Biologial Assets | -$1.46 | -$2.04 | -$1.93 | -$3.58 | -$3.43 |
| Gross Margin | $0.64 | $2.02 | $2.79 | $4.63 | $3.31 |
| Marketing and Sales | |||||
| Investor Relations | $1.23 | ||||
| Total Operating Expenses | $2.22 | $3.71 | $2.91 | $15.63 | $5.78 |
| Operating Cash Flow | -$1.60 | -$1.70 | -$1.08 | $3.76 | -$6.57 |
| Investing Cash Flow | -$8.89 | -$6.88 | -$1.48 | -$20.49 | $8.09 |
| Financing Cash Flow | $34.26 | -$0.14 | $0.34 | $0.52 | $0.50 |
Financial Statements
Listing Statement
All of the information on this dashboard was collected on a best efforts basis. This information should not be relied upon to make investment decisions. Always do your own diligence when purchasing a security and contact a licensed financial representative.